Appaloosa
Streaks
New in this book this quarter: BA, AAL, CRWV, AVGO, SPCX and 1 more.
Over time
Filings
- Q2 2026 filed Aug 14, 26 $7.5B · 25 positions · 6 new · 12 exited full · Concentrated 6 new · 12 exited
- Q1 2026 filed May 15, 26 $5.9B · 31 positions · 1 new · 8 exited full · Concentrated 1 new · 8 exited
- Q4 2025 filed Feb 17, 26 $6.9B · 38 positions · 2 new · 9 exited full · Focused 2 new · 9 exited
- Q3 2025 filed Nov 13, 25 $7.4B · 45 positions · 10 new · 3 exited full · Concentrated 10 new · 3 exited
- Q2 2025 filed Aug 14, 25 $6.4B · 38 positions · 8 new · 5 exited full · Concentrated 8 new · 5 exited
- Q1 2025 filed May 15, 25 $5.6B · 35 positions · 4 new · 6 exited partial · Concentrated 4 new · 6 exited
- Q4 2024 filed Feb 10, 25 $6.5B · 37 positions · 1 new · 2 exited full · Concentrated 1 new · 2 exited
- Q3 2024 filed Nov 14, 24 $6.7B · 38 positions · 4 new · 3 exited full · Concentrated 4 new · 3 exited
- Q2 2024 filed Aug 14, 24 $6.2B · 37 positions · 0 new · 1 exited full · Concentrated 0 new · 1 exited
- Q1 2024 filed May 15, 24 $6.7B · 38 positions · 6 new · 7 exited full · Concentrated 6 new · 7 exited
- Q4 2023 filed Feb 14, 24 $5.7B · 39 positions · 10 new · 3 exited full · Concentrated 10 new · 3 exited
- Q3 2023 filed Nov 14, 23 $5.1B · 32 positions · 1 new · 8 exited full · Concentrated 1 new · 8 exited
- Q2 2023 filed Aug 14, 23 $5.4B · 39 positions · 19 new · 8 exited full · Focused 19 new · 8 exited
- Q1 2023 filed May 15, 23 $1.9B · 28 positions · 5 new · 1 exited full · Concentrated 5 new · 1 exited
- Q4 2022 filed Feb 14, 23 $1.3B · 24 positions · 3 new · 1 exited full · Concentrated 3 new · 1 exited
- Q3 2022 filed Nov 14, 22 $1.4B · 22 positions · 0 new · 8 exited full · Concentrated 0 new · 8 exited
- Q2 2022 filed Aug 15, 22 $1.6B · 30 positions · 8 new · 12 exited full · Concentrated 8 new · 12 exited
- Q1 2022 filed May 16, 22 $2.5B · 34 positions · 2 new · 12 exited full · Concentrated 2 new · 12 exited
- Q4 2021 filed Feb 14, 22 $3.9B · 44 positions · 5 new · 12 exited full · Focused 5 new · 12 exited
- Q3 2021 filed Nov 15, 21 $4.2B · 51 positions · 3 new · 6 exited full · Focused 3 new · 6 exited
- Q2 2021 filed Aug 16, 21 $4.8B · 54 positions · 4 new · 12 exited full · Focused 4 new · 12 exited
- Q1 2021 filed May 17, 21 $7.0B · 62 positions · 23 new · 6 exited full · Focused 23 new · 6 exited
- Q4 2020 filed Feb 16, 21 $6.7B · 45 positions · 16 new · 3 exited full · Concentrated 16 new · 3 exited
- Q3 2020 filed Nov 16, 20 $5.7B · 32 positions · 1 new · 6 exited full · Concentrated 1 new · 6 exited
- Q2 2020 filed Aug 14, 20 $5.8B · 37 positions · 12 new · 5 exited full · Concentrated 12 new · 5 exited
- Q1 2020 filed May 15, 20 $3.3B · 30 positions · 13 new · 5 exited full · Concentrated 13 new · 5 exited
- Q4 2019 filed Feb 14, 20 $3.9B · 22 positions · 2 new · 4 exited full · Very concentrated 2 new · 4 exited
- Q3 2019 filed Nov 14, 19 $3.4B · 24 positions · 3 new · 2 exited full · Concentrated 3 new · 2 exited
- Q2 2019 filed Aug 14, 19 $2.3B · 23 positions · 3 new · 2 exited fragment · Very concentrated 3 new · 2 exited
- Q1 2019 filed May 15, 19 $3.4B · 22 positions · 8 new · 8 exited full · Very concentrated 8 new · 8 exited
- Q4 2018 filed Feb 14, 19 $2.0B · 22 positions · 4 new · 18 exited full · Very concentrated 4 new · 18 exited
- Q3 2018 filed Nov 14, 18 $5.6B · 36 positions · 3 new · 14 exited full · Very concentrated 3 new · 14 exited
- Q2 2018 filed Aug 14, 18 $8.7B · 47 positions · 6 new · 11 exited full · Concentrated 6 new · 11 exited
- Q1 2018 filed May 15, 18 $9.6B · 52 positions · 14 new · 8 exited full · Concentrated 14 new · 8 exited
- Q4 2017 filed Feb 14, 18 $10.4B · 46 positions · 12 new · 13 exited full · Concentrated 12 new · 13 exited
- Q3 2017 filed Nov 14, 17 $6.9B · 47 positions · 3 new · 13 exited full · Focused 3 new · 13 exited
- Q2 2017 filed Aug 14, 17 $6.7B · 57 positions · 23 new · 18 exited full · Focused 23 new · 18 exited
- Q1 2017 filed May 12, 17 $5.7B · 52 positions · 10 new · 11 exited full · Focused 10 new · 11 exited
- Q4 2016 filed Feb 14, 17 $5.4B · 53 positions · 21 new · 9 exited full · Concentrated 21 new · 9 exited
- Q3 2016 filed Nov 14, 16 $3.9B · 41 positions · 12 new · 8 exited mostly · Concentrated 12 new · 8 exited
- Q2 2016 filed Aug 12, 16 $3.8B · 37 positions · 4 new · 14 exited full · Concentrated 4 new · 14 exited
- Q1 2016 filed May 13, 16 $5.0B · 47 positions · 10 new · 14 exited mostly · Focused 10 new · 14 exited
- Q4 2015 filed Feb 12, 16 $4.4B · 51 positions · 25 new · 6 exited mostly · Focused 25 new · 6 exited
- Q3 2015 filed Nov 13, 15 $2.8B · 32 positions · 5 new · 7 exited full · Concentrated 5 new · 7 exited
- Q2 2015 filed Aug 14, 15 $4.0B · 34 positions · 3 new · 3 exited full · Concentrated 3 new · 3 exited
- Q1 2015 filed May 15, 15 $4.2B · 34 positions · 9 new · 3 exited mostly · Concentrated 9 new · 3 exited
- Q4 2014 filed Feb 13, 15 $4.0B · 28 positions · 1 new · 15 exited full · Concentrated 1 new · 15 exited
- Q3 2014 filed Nov 14, 14 $6.8B · 42 positions · 5 new · 13 exited full · Focused 5 new · 13 exited
- Q2 2014 filed Aug 14, 14 $7.1B · 50 positions · 4 new · 10 exited full · Focused 4 new · 10 exited
- Q1 2014 filed May 15, 14 $7.5B · 56 positions · 3 new · 14 exited mostly · Focused 3 new · 14 exited
- Q4 2013 filed Feb 14, 14 $8.0B · 67 positions · 19 new · 14 exited full · Concentrated 19 new · 14 exited
- Q3 2013 filed Nov 14, 13 $6.2B · 62 positions · 6 new · 12 exited full · Focused 6 new · 12 exited
- Q2 2013 filed Aug 13, 13 $6.9B · 68 positions · 0 new · 0 exited full · Concentrated 0 new · 0 exited






